EL ESTEE LAUDER COMPANIES INC
Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1001250 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.8%
TTM net income YoY139.6%
TTM EPS YoY139.0%
Revenue 3-yr CAGR-0.5%
Net income 3-yr CAGR-12.9%
Margins
Gross margin76.0%
Operating margin6.7%
Net margin2.4%
FCF margin9.9%
EBITDA margin11.8%
Returns
ROE9.3%
ROA1.9%
ROIC (approx.)6.1%
Asset turnover0.78x
Leverage & solvency
Liabilities / assets79.8%
Debt / equity1.67x
Current ratio1.25x
Interest coverage3.08x
Cash quality & payout
Operating cash flow / net income5.29x
Accruals ratio-8.0%
Payout ratio137.8%
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2026*2026-06-30 | FY2025*2025-06-30 | FY2024*2024-06-30 | FY2023*2023-06-30 | FY2022*2022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $15.05B | $14.33B | $15.61B | $15.91B | $17.74B |
| Cost of revenue | $3.69B | $3.73B | $4.42B | $4.56B | $4.30B |
| Gross profit | $11.36B | $10.60B | $11.18B | $11.35B | $13.43B |
| SG&A expense | $9.69B | $9.46B | $9.62B | $9.57B | $9.89B |
| Operating income | $780.00M | -$785.00M | $970.00M | $1.51B | $3.17B |
| Interest expense | $334.00M | $357.00M | $378.00M | $255.00M | $167.00M |
| Pretax income | $517.00M | -$1.04B | $772.00M | $1.40B | $3.04B |
| Income tax | $335.00M | $93.00M | $363.00M | $387.00M | $628.00M |
| Net income | $182.00M | -$1.13B | $409.00M | $1.01B | $2.40B |
| EBITDA | $1.58B | $44.00M | $1.79B | $2.25B | $3.90B |
| EPS (basic) | 0.50 | -3.15 | 1.09 | 2.81 | 6.64 |
| EPS (diluted) | 0.50 | -3.15 | 1.08 | 2.79 | 6.55 |
| Dividends declared per share | 1.40 | 1.71 | 2.64 | 2.58 | 2.33 |
| Weighted avg. shares (diluted) | 364.80M | 360.10M | 360.80M | 360.90M | 364.90M |
| Balance sheet | |||||
| Cash & equivalents | $3.50B | $2.92B | $3.40B | $4.03B | $3.96B |
| Receivables | $1.52B | $1.53B | $1.73B | $1.45B | $1.63B |
| Inventory | $2.00B | $2.07B | $2.17B | $2.98B | $2.92B |
| Current assets | $7.61B | $7.07B | $7.92B | $9.14B | $9.30B |
| PP&E, net | $2.81B | $3.17B | $3.14B | $3.18B | $2.65B |
| Goodwill | $2.11B | $2.13B | $2.14B | $2.49B | $2.52B |
| Intangibles | $3.58B | $3.76B | $5.18B | $5.60B | $3.43B |
| Total assets | $19.76B | $19.89B | $21.68B | $23.41B | $20.91B |
| Current liabilities | $6.23B | $5.43B | $5.70B | $6.24B | $5.82B |
| Short-term debt | $503.00M | $3.00M | $504.00M | $997.00M | $268.00M |
| Long-term debt | $6.80B | $7.31B | $7.27B | $7.12B | $5.14B |
| Total debt | $7.31B | $7.32B | $7.77B | $8.11B | $5.41B |
| Total liabilities | $15.96B | $16.03B | $16.36B | $17.00B | $14.48B |
| Shareholders' equity | $3.81B | $3.87B | $5.31B | $5.58B | $5.59B |
| Net debt | $3.81B | $4.40B | $4.38B | $4.08B | $1.46B |
| Cash flow statement | |||||
| Operating cash flow | $1.77B | $1.27B | $2.36B | $1.73B | $3.04B |
| Capital expenditure | $457.00M | $602.00M | $919.00M | $1.00B | $1.04B |
| Free cash flow | $1.32B | $670.00M | $1.44B | $728.00M | $2.00B |
| Investing cash flow | -$489.00M | -$623.00M | -$960.00M | -$3.22B | -$945.00M |
| Financing cash flow | -$712.00M | -$1.14B | -$2.04B | $1.59B | -$3.04B |
| Depreciation & amortization | $796.00M | $829.00M | $825.00M | $744.00M | $727.00M |
| Stock-based compensation | $310.00M | $304.00M | $325.00M | $267.00M | $331.00M |
| Dividends paid | $508.00M | $618.00M | $947.00M | $925.00M | $840.00M |
| Share buybacks | $70.00M | $35.00M | $35.00M | $271.00M | $2.31B |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.